Antimicrobial activities of silver dressings: an in vitro comparison.

A range of silver-coated or -impregnated dressings are now commercially available for use but comparative data on their antimicrobial efficacies are limited. The antibacterial activities of five commercially available silver-coated/impregnated dressings were compared against nine common burn-wound pathogens, namely methicillin-sensitive and -resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Proteus vulgaris, Acinetobacter baumannii and a multi-drug-efflux-positive Acinetobacter baumannii (BM4454), using a broth culture method. The rapidity and extent of killing of these pathogens under in vitro conditions were evaluated. All five silver-impregnated dressings investigated exerted bactericidal activity, particularly against Gram-negative bacteria, including Enterobacter species, Proteus species and E. coli. The spectrum and rapidity of action, however, ranged widely for different dressings. Acticoat and Contreet had a broad spectrum of bactericidal activities against both Gram-positive and -negative bacteria. Contreet was characterized by a very rapid bactericidal action and achieved a reduction of > or =10,000 c.f.u. ml(-1) in the first 30 min for Enterobacter cloacae, Proteus vulgaris, Pseudomonas aeruginosa and Acinetobacter baumanii. Other dressings demonstrated a narrower range of bactericidal activities. Understanding the characteristics of these dressings may enable them to be targeted more appropriately according to the specific requirements for use of a particular dressing, as in for prophylaxis in skin grafting or for an infected wound with MRSA.

[1]  Ben Wong,et al.  Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? , 2004, The Journal of antimicrobial chemotherapy.

[2]  K. Harding,et al.  Wound dressings in diabetic foot disease. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  P. Bowler,et al.  Controlling wound bioburden with a novel silver‐containing Hydrofiber® dressing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[4]  V. Poon,et al.  In vitro cytotoxity of silver: implication for clinical wound care. , 2004, Burns : journal of the International Society for Burn Injuries.

[5]  R. Kimble,et al.  An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. , 2004, Burns : journal of the International Society for Burn Injuries.

[6]  K. Andersen,et al.  Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. , 2003, Journal of wound care.

[7]  S. Silver,et al.  Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. , 2003, FEMS microbiology reviews.

[8]  S. Thomas,et al.  A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. , 2003, Journal of wound care.

[9]  A. Lansdown,et al.  Silver. 2: Toxicity in mammals and how its products aid wound repair. , 2002, Journal of wound care.

[10]  A. Lansdown,et al.  Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.

[11]  S. Magnet,et al.  Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.

[12]  R. White An historical overview of the use of silver in wound management , 2001 .

[13]  H J Klasen,et al.  Historical review of the use of silver in the treatment of burns. I. Early uses. , 2000, Burns : journal of the International Society for Burn Injuries.

[14]  R. Darouiche Anti-infective efficacy of silver-coated medical prostheses. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  E Olsson,et al.  Silver-based crystalline nanoparticles, microbially fabricated. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Burrell,et al.  Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. , 1998, American journal of infection control.

[17]  A. Gupta,et al.  Effects of Halides on Plasmid-Mediated Silver Resistance in Escherichia coli , 1998, Applied and Environmental Microbiology.

[18]  J. Marshall,et al.  Systemic argyria secondary to topical silver nitrate. , 1977, Archives of dermatology.

[19]  D. Chinkes,et al.  Therapeutic efficacy of three silver dressings in an infected animal model. , 2005, The Journal of burn care & rehabilitation.

[20]  K. Foster,et al.  Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. , 2004, The Journal of burn care & rehabilitation.

[21]  D. Ross,et al.  The use of cerium nitrate-silver sulphadiazine as a topical burns dressing. , 1993, British journal of plastic surgery.